COMMUNIQUÉS West-GlobeNewswire

Synthorx to Present at H.C. Wainwright Global Life Sciences Conference in London

02/04/2019 - 14:00

SAN DIEGO, April 02, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]

IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA

02/04/2019 - 14:00

SAINT LAURENT, Quebec, April 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced it has received a Complete Response Letter (“CRL”) [...]

NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019

02/04/2019 - 14:00

AMES, Iowa, April 02, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced results from a Phase 2 study of NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor camptothecin [...]

Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam

02/04/2019 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., April 02, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]

Cabaletta Bio Appoints Distinguished Immunotherapist and Cell Therapy Expert, Catherine Bollard, M.D., to its Board of Directors

02/04/2019 - 14:00

RADNOR, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, announced today the [...]

Calithera Biosciences Presents New Preclinical Data for CB-708 at AACR Annual Meeting 2019

02/04/2019 - 13:05

Oral CD73 inhibitor enhances the effect of checkpoint blockade and chemotherapy SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology [...]

Myriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal Tests

02/04/2019 - 13:05

SALT LAKE CITY, April 02, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present results from [...]

Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update

02/04/2019 - 13:05

– Key focus on advancing the development of MAT9001, a potential best-in-class cardiovascular therapy in what is projected to be a new, multi-billion dollar prescription-only omega-3 market – – Company continues to [...]

Helius Medical Technologies to Release First Quarter of Fiscal Year 2019 Financial Results on May 9, 2019

02/04/2019 - 13:05

NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that first [...]

Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference

02/04/2019 - 13:00

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 2 April 2019 – Summit Therapeutics plc [...]

Zealand Pharma to attend Needham Healthcare Conference

02/04/2019 - 13:00

Press release – No. 06 / 2019 Zealand Pharma to attend Needham Healthcare Conference Copenhagen, April 2, 2019 – Adam Steensberg, Interim Chief Executive Officer, and Marino Garcia, Senior Vice President of Corporate [...]

G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference

02/04/2019 - 13:00

RESEARCH TRIANGLE PARK, N.C., April 02, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a [...]

Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference

02/04/2019 - 13:00

SAN DIEGO and TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of [...]

IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor

02/04/2019 - 13:00

WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2 [...]

Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting

02/04/2019 - 13:00

– Tilsotolimod activated IFN-α and MHC class II genes in the tumor microenvironment across multiple tumor types – EXTON, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a [...]

EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences

02/04/2019 - 13:00

WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2019 Highlight Evolution of ETB Platform

02/04/2019 - 13:00

Presentations from multiple pipeline programs feature data demonstrating continued evidence of forced internalization with CD38 and PD-L1 leads, dramatically improved tolerability in NHP models, enhanced potency, and [...]

Trillium Therapeutics Expands Immuno-Oncology Pipeline With STING Agonist Program

02/04/2019 - 13:00

- Preclinical data presented at the 2019 AACR Annual Meeting TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative [...]

Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer

02/04/2019 - 13:00

NEW HAVEN, Conn., April 02, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrades disease-causing proteins, announced that two members of the [...]